Abivax names four commercial leaders ahead of planned NDA filing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Abivax names four commercial leaders ahead of planned NDA filing

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

July 23, 2026 4:05 PM EDT

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Appointed industry leaders bring decades of experience across commercial strategy, patient services, launch readiness, and field force development

PARIS, France July 23, 2026 10:05 p.m. CEST Abivax SA (Euronext Paris: FR0012333284 ABVX / Nasdaq: ABVX) (Abivax or the Company), a clinical-stage biotechnology company focused on developing therapeutics that harness the bodys natural regulatory mechanisms to stabilize the immune response in... More